clinical_trial 1,131 words KG: OVERVIEW
Contents

bld-2660-msa-nct05224379

Knowledge Graph

Related Hypotheses (1)

Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.63

Related Analyses (22)

4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived

Related Experiments (6)

Iron Dyshomeostasis in MSA Pathogenesis Experiment
validation · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy
validation · proposed · Score: 0.40
Non-Motor Symptom Progression in Parkinson's Disease — Mecha
clinical · proposed · Score: 0.40
Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel
validation · proposed · Score: 0.40

Knowledge Graph (12 edges)

OVERVIEW biomarker_for BRAF
OVERVIEW biomarker_for ATRX
OVERVIEW activates VALOSIN
OVERVIEW therapeutic_target CXCR1
OVERVIEW regulates LETM1
OVERVIEW regulates MCU
OVERVIEW activates CHMP2B
OVERVIEW activates TARDBP
OVERVIEW activates LC3
OVERVIEW activates TBK1

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)